Committed under
Chimerna Therapeutics, Inc.
$256,158 committed in all years on record · 0.0% of the program
- Full records
- Chimerna Therapeutics, Inc. → everything they’re paid, across every program and agencyExtramural Research Programs in the Neurosciences and Neurological Disorders → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Extramural Research Programs in the Neurosciences and Neurological Disorders dollars committed to Chimerna Therapeutics, Inc., per fiscal year.
Awards
The largest awards to Chimerna Therapeutics, Inc. under this program.
A Novel TDP-43-TARGETING Circular Rna to Treat Amyotrophic Lateral Sclerosis (ALS) - Summary Amyotrophic Lateral Sclerosis (ALS) Is a Fatal …
Feb 10, 2025$256,158
Circular Mimics of Iron-response Elements to Inhibit Ferroptosis - Summary: Iron Overload Is Found in Nearly All Patients With Parkinson's D…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants
